当前位置: 首页 >> 检索结果
64. Application of a novel Musculoskeletal Ultrasound Sum Score (MUSS) in the follow-up of patients with juvenile idiopathic arthritis.
To evaluate the novel Musculoskeletal Ultrasound Sum Score (MUSS) as a longitudinal marker of disease activity (DA) in patients with juvenile idiopathic arthritis (JIA) within a treat-to-target management approach.
65. Urological manifestations in familial mediterranean fever excluding renal amyloidosis: a systematic review.
作者: Aziz Kutay Ozcan.;Baris Karaoglan.;Berkay Gundogdu.;Cansu Sahin.;Muhammed Fatih Simsekoglu.;Serdal Ugurlu.
来源: Rheumatology (Oxford). 2026年
To systematically review the spectrum of urological manifestations and fertility outcomes reported in FMF patients, excluding renal amyloidosis-related involvement.
66. Soluble SIGLEC1 as a biomarker of disease activity in idiopathic inflammatory myopathies.
作者: Nathan Barreth.;Valérie Leclair.;Marie Hudson.;Sasha Bernatsky.;Eugene Krustev.;Cristina Moran Toro.;Yvan St Pierre.;Ashley Clarke.;Paul J A Sciore.;Mark Tarnopolsky.;Marvin J Fritzler.;May Y Choi.; .
来源: Rheumatology (Oxford). 2026年
To investigate soluble circulating sialic acid-binding Ig-like lectin 1 (scSIGLEC1), a surrogate biomarker for type I interferon, as a novel biomarker for idiopathic inflammatory myopathies (IIM) disease activity.
67. A treat-to-target strategy versus symptom-driven management of gout in the Netherlands (GO TEST Overture): a multicentre, open-label, pragmatic, superiority, randomised controlled trial.
作者: Anusha Moses.;Martijn A H Oude Voshaar.;Eva H van Geel.;Lydia Schipper.;Iris Rose Peeters.;Reinhard Bos.;Caroline van Durme.;Mart A F J van de Laar.;Tim L Jansen.
来源: Lancet Rheumatol. 2026年
A treat-to-target approach is recommended for gout management, which involves titrating urate-lowering therapy to reach a serum urate target of less than 0·36 mmol/L, but evidence from pragmatic, head-to-head trials comparing a treat-to-target strategy with a symptom-driven approach is scarce. We aimed to address this gap by comparing these two approaches in patients with gout.
69. Rheumatologist assessment in established polymyalgia rheumatica.
作者: Elisabeth Lindrup Nielsen.;Agnete Overgaard Donskov.;Christoffer Søvsø Våben.;Andreas Wiggers Nielsen.;Line Lier Frølund.;Ib Tønder Hansen.;Line Thorndal Moll.;Berit Dalsgaard Nielsen.;Christoffer Mørk.;Ellen-Margrethe Hauge.;Kresten Krarup Keller.
来源: Rheumatology (Oxford). 2026年
Patients with established polymyalgia rheumatica (PMR) are often referred from general practitioners (GPs) to rheumatologists.This single-center cohort study examined the frequency, indications, and diagnostic outcomes of patients with established PMR referred to a rheumatology outpatient clinic after initial diagnosis by GPs or rheumatologists in a hospital outpatient setting.
70. Central pain sensitivity is associated with changes in fatigue in rheumatoid arthritis: data from the CAP-RA study.
作者: Vasileios Georgopoulos.;Stephanie L Smith.;David A Walsh.;Daniel F McWilliams.
来源: Rheumatology (Oxford). 2026年
This observational study examined whether central pain sensitivity is associated with fatigue in rheumatoid arthritis (RA) and whether such associations are explained by pain severity or inflammation.
71. Sex-based differences in bDMARD initiation and persistence in spondyloarthritis: a 17-year follow-up study from the REGISPON-3 registry.
作者: Diana Maria Margareta Moldovan.;Lourdes Ladehesa-Pineda.;María Ángeles Puche-Larrubia.;María Carmen Ábalos-Aguilera.;Desirée Ruiz-Vilchez.;Raquel Ena María Granados.;Carlos M Collantes-Sánchez.;Alejandro Escudero-Contreras.; .;Eduardo Collantes-Estévez.;Clementina López-Medina.
来源: Rheumatology (Oxford). 2026年
This study examines sex differences in the initiation and retention rate of biological disease-modifying antirheumatic drugs (bDMARDs) among patients with spondyloarthritis (SpA) over a 17-year follow-up period, and identifies sex-specific predictors of these treatment outcomes.
72. Exploring sleep health and circadian rhythm disruption in Sjögren's disease: an accelerometric and self-reported cross-sectional study.
作者: Caterina Di Pede.;Alessandro Colitta.;Simone Bruno.;Paolo Frumento.;Michelangelo Maestri Tassoni.;Giovanni Fulvio.;Gaetano La Rocca.;Enrica Bonanni.;Marta Mosca.;Rosaria Talarico.;Chiara Baldini.;Ugo Faraguna.
来源: Rheumatology (Oxford). 2026年
In a cross-sectional study, we aimed at characterizing possible impairments in sleep health and rest-activity parameters between patients with Sjögren's Disease (SjD) and healthy controls (HCs). Furthermore, we explored possible predictors of such disturbances in the SjD group.
73. Treatment satisfaction, disease severity, and health-care use in patients with axial spondyloarthritis in the United States and Europe.
作者: Elena Nikiphorou.;Alexis Ogdie.;Dan Twigg.;Emily Quiñones.;You-Li Ling.;Joseph C Cappelleri.;Lidia Sanchez-Riera.;Karim R Masri.;Megan Hughes.;Nicola Massey.
来源: Rheumatology (Oxford). 2026年65卷3期
The heterogeneous presentation of axial SpA (axSpA) complicates diagnosis and treatment decisions. This study compared patient symptoms, health-care resource utilization, and physician-patient alignment on disease severity and treatment satisfaction between the USA and five European countries (5EU).
76. Incident rheumatoid arthritis and work loss: a nationwide sibling comparison study.
作者: Heather Miller.;Gustaf Bruze.;Kari Johansson.;Johan Askling.;Martin Neovius.
来源: Rheumatology (Oxford). 2026年
Rheumatoid arthritis (RA) has been associated with substantial work loss, but advances in treatment have improved clinical outcomes for patients over time calling for an updated assessment. We therefore aimed to examine calendar trends in the association between RA diagnosis and work loss.
77. Clinical phenotype, MRI inflammatory involvement, and treatment patterns in HLA-B27 positive and negative axial spondyloarthritis: a Saudi MRI-based cohort study.
作者: Abdallah Alqethami.;Mohammed Basalama.;Samiyah Alsaedi.;Khulud Alqahtani.;Eman Alsindi.;Sabri Alsaeedi.;Roaa Mahroos.;Maysoon Taher.
来源: BMC Rheumatol. 2026年 78. Assessing disease activity in inflammatory arthritis using optical spectral transmission: a systematic review compared to joint ultrasound, MRI, and clinical activity markers.
作者: Ann-Kathrin Druck.;Chandana Keshavamurthy.;Mohammed Alhaddad.;Andreas V Goules.;Andreas Schwarting.;Konstantinos Triantafyllias.
来源: BMC Rheumatol. 2026年 80. Bimekizumab safety and efficacy in patients with psoriatic arthritis: 3-year results from two phase 3 studies.
作者: Laure Gossec.;Laura C Coates.;Robert B M Landewé.;Philip J Mease.;Joseph F Merola.;Christopher T Ritchlin.;Yoshiya Tanaka.;Akihiko Asahina.;Fabian Proft.;Nadine Goldammer.;Myriam Manente.;Barbara Ink.;Rajan Bajracharya.;Jason Coarse.;Iain B McInnes.
来源: Rheumatology (Oxford). 2026年
Bimekizumab, a monoclonal IgG1 antibody that selectively inhibits interleukin (IL)-17F in addition to IL-17A, has demonstrated tolerability and clinical efficacy in patients with psoriatic arthritis (PsA). Here, we report an additional year of safety and efficacy of bimekizumab to 3 years.
|